MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1.

about

MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1.

Item

http://www.wikidata.org/entity/Q55492687

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@en

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@nl

type

Item

label

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@en

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@nl

prefLabel

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@en

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@nl

P1476

MiR-92a Inhibits the Progress ...... nsitivity by Targeting Notch1.

@en

P2093

Quanxiang Liu

http://www.w3.org/2001/XMLSchema#string

Xianliang Duan

http://www.w3.org/2001/XMLSchema#string

Yang Song

http://www.w3.org/2001/XMLSchema#string

Yuan Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer

MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells

Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.

miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma

Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone

The epidemiology of osteosarcoma.

Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response.

Targeting Notch signaling pathway to overcome drug resistance for cancer therapy

Osteosarcoma treatment - where do we stand? A state of the art review.

P304

9870693

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/9870693

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Jianping Guo

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29984257

http://www.w3.org/2001/XMLSchema#string

P932

6011149

http://www.w3.org/2001/XMLSchema#string